These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Energy landscape of aptamer/protein complexes studied by single-molecule force spectroscopy. Yu J; Jiang Y; Ma X; Lin Y; Fang X Chem Asian J; 2007 Feb; 2(2):284-9. PubMed ID: 17441163 [TBL] [Abstract][Full Text] [Related]
48. In vitro selection of protein-binding DNA aptamers as ligands for biosensing applications. Navani NK; Mok WK; Yingfu L Methods Mol Biol; 2009; 504():399-415. PubMed ID: 19159108 [TBL] [Abstract][Full Text] [Related]
49. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway. DeCicco KL; Tanaka T; Andreola F; De Luca LM Carcinogenesis; 2004 Oct; 25(10):1805-12. PubMed ID: 15205358 [TBL] [Abstract][Full Text] [Related]
50. Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood. Zamay GS; Kolovskaya OS; Zamay TN; Glazyrin YE; Krat AV; Zubkova O; Spivak E; Wehbe M; Gargaun A; Muharemagic D; Komarova M; Grigorieva V; Savchenko A; Modestov AA; Berezovski MV; Zamay AS Mol Ther; 2015 Sep; 23(9):1486-96. PubMed ID: 26061649 [TBL] [Abstract][Full Text] [Related]
53. The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods. Tang J; Xie J; Shao N; Yan Y Electrophoresis; 2006 Apr; 27(7):1303-11. PubMed ID: 16518777 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers. Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143 [TBL] [Abstract][Full Text] [Related]
55. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752 [TBL] [Abstract][Full Text] [Related]
57. In vitro lectin-mediated selection and characterization of rHuEPO-α-binding ssDNA aptamers. Zhang Z; Guo L; Guo A; Xu H; Tang J; Guo X; Xie J Bioorg Med Chem; 2010 Nov; 18(22):8016-25. PubMed ID: 20971648 [TBL] [Abstract][Full Text] [Related]
58. Probing interactions between human lung adenocarcinoma A549 cell and its aptamers at single-molecule resolution. Wang Q; Zhou C; Yang X; Liu L; Wang K J Mol Recognit; 2014 Nov; 27(11):676-82. PubMed ID: 25277092 [TBL] [Abstract][Full Text] [Related]
59. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX. Dastjerdi K; Tabar GH; Dehghani H; Haghparast A Biotechnol Appl Biochem; 2011; 58(4):226-30. PubMed ID: 21838796 [TBL] [Abstract][Full Text] [Related]
60. Aptamers: a promising tool for cancer imaging, diagnosis, and therapy. Liu K; Lin B; Lan X J Cell Biochem; 2013 Feb; 114(2):250-5. PubMed ID: 22949372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]